Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

User Fees Poised For 18% FY 2005 Hike; Compensating Adjustment Delayed

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed and the Medical Device Manufacturers Association will meet with their respective members in coming weeks to address a proposed 18.3% user fee increase

You may also be interested in...



User Fees To Rise 16% As FDA Backs Historical Data Over Industry Estimates

FDA is declining to adopt an industry proposal that would have halved the agency's projected 18% PMA user fee hike for fiscal 2005

User Fees To Rise 16% As FDA Backs Historical Data Over Industry Estimates

FDA is declining to adopt an industry proposal that would have halved the agency's projected 18% PMA user fee hike for fiscal 2005

Ubl’s Successor At AdvaMed Will Struggle To Maintain User Fee Stability

AdvaMed Exec VP-Federal Government Relations Steve Ubl will be absent from the negotiating table July 15 when FDA meets with industry reps to discuss counterproposals to an 18% hike in 2005 user fee rates

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020334

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel